Fact CheckerSign in

NCT01422421CompletedPhase 4

Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease

Intensive Blood Pressure and LDL Lowering for Better Survival and Cardiovascular Outcome in Diabetic Patients With Coronary Artery Disease: Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 14 Jun 2024

Brief summary (registry, in English)

The purpose of this study is to determine whether intensive blood pressure and low density lipoprotein (LDL) cholesterol lowering could improve survival and cardiovascular outcome in Japanese diabetic patients with coronary artery disease and history of acute coronary syndrome.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
798 (actual)
First submitted
23 Aug 2011
Start date
Aug 2011
Primary completion date
31 Mar 2022
Lead sponsor
Takeshi Morimoto
NCT number
NCT01422421

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 798
  • From Aug 2011 to the primary completion date, 31 Mar 2022
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients who have active malignant tumor
  • Patients who are on hemodialysis due to end stage kidney disease
  • Patients who had acute coronary syndrome or stroke within 3 months

Other

  • Patients whom statins are contraindicated
  • Patients who are pregnant or on breast feeding
  • Patients whose physicians deem that attending this trial is contraindicated or inappropriate

Who the study is looking for

  • Type 2 diabetic patients with coronary artery disease and history of acute coronary syndrome
  • Patients whose blood pressure and LDL cholesterol levels are above values recommended by the current guideline

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital, University of the Ryukyus
Coordinator of this site? Confirm its status
NishiharaJapanUnknown status
Saga University Hospital
Coordinator of this site? Confirm its status
SagaJapanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.